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Primary malignant lymphomas of the lung are very rare. Most of them are extranodal marginal zone
B-cell lymphoma of MALT type. Primary follicular lymphoma of the lung is extremely rare. A 50-year-old
woman presented with cough and sputum, and consulted to a private hospital, where she was pointed
out to have abnormal lung shadow by chest XeP. She was admitted to our hospital for scrutiny. Imaging
modalities including CT, MRI, and PET revealed a small (15 mm in diameter) nodule in the right middle
lobe beneath the pleura. No other tumors were found by these techniques. A biopsy revealed a lymphoid
proliferation. Clinical cytology was negative. A wedge resection with wide margins was performed.
Grossly, the resected lung specimen contained a white solid mass measuring 12  13  13 mm.
Microscopically, the mass was composed of follicular proliferation of atypical lymphocytes. There were
no tingible body macrophages, and normal follicular polarity was absent. Mild inﬁltrative growth from
the surrounding lung was present. Lymphoepithelial lesions were not recognized. The atypical
lymphocytes consisted of centrocytes, centroblasts, and small lymphoid cuffs. The centroblasts are seen
in 3e5 per a high power ﬁeld. The immunophenotypes were CD45 þ, CD5 þ, CD10 þ, CD23 þ, cyclin D1
, CD20 þ, CD21 þ, CD79a þ, bcl-2 þ, bcl-6 , CD3 , CD45RO , CD30 , CD15 , k-chain þ, and
l-chain . The Ki-67 labeling was 36%. The overall appearances suggested that the lesion was primary
pulmonary follicular lymphoma, grade I. Discussion of differential diagnosis from nodular lymphoid
hyperplasia, extranodal marginal zone lymphoma of MALT type, and mantle cell lymphoma was made.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Primarypulmonarymalignant lymphomas are very rare.1e4Most
of them are extranodal marginal zone B-cell lymphoma of MALT
type. Primary pulmonary follicular lymphoma is extremely rare.1,5
The author here reports a case of primary pulmonary follicular
lymphoma. This lymphoma was very difﬁcult to differentiate from
extranodal marginal B-cell zone lymphoma of MALT type.2. Case report
A 50-year-old woman presented with cough and sputum, and
consulted to a private hospital, where she was pointed out to have
abnormal lung shadow by chest XeP. She was admitted to our
hospital for scrutiny. Imagingmodalities including CT, MRI, and PET
revealed a small (15 mm in diameter) nodule in the right middle
lobe beneath the pleura. No other tumors were found by these
techniques. A biopsy revealed a lymphoid proliferation. Clinical
cytology was negative.rved.A video-assisted thoracoscopic wedge resection with wide
margins was performed. Grossly, the resected lung specimen con-
tained a white solid mass measuring 12  13  13 mm (Fig. 1).
Microscopically, the mass was composed of follicular proliferation
of atypical lymphocytes (Fig. 2a and b). Mild inﬁltrative growth
from the surrounding lung was present. There were no tingible
body macrophages in the follicles, and the normal polarity of
lymphoid follicles is absent. Lymphoepithelial lesions were not
recognized. The atypical lymphocytes consisted of centrocytes,
centroblasts, and small lymphoid cuffs (Fig. 2b and c). The centro-
blasts are seen in 3e5 per a high power ﬁeld (Fig. 2c).
An immunohistochemical study was performed with the use of
Dako Envision method, as previously described.6e8 The antibodies
used were as follows: cytokeratins (AE1/3, Dako, Glostrup,
Denmark), cytokeratin (CAM5.2, Bekton-Dickinson, CA, USA), CD45
(LCA, Dako), CD20 (L26, Dako), CD79a (SN8, Dako), CD21 (1F8,
Dako), CD23 (MHM6, Dako), cyclin D1 (DCS-22, Dako), bcl-2 (124,
Dako), bcl-6 (PG-B6P, Dako), CD5 (DK23, Dako), CD10 (SS2/6, Dako),
CD3 (PC3/188A, Dako), CD45RO (UCHL-1, Dako), CD30 (Ber-H2,
Dako), CD15 (C34D1, Dako), k-chain (polyclonal, Dako), l-chain
(polyclonal, Dako).
The tumor cells were negative for cytokeratins. The immuno-
phenotypes of the lymphocytes in the present tumor were as
Fig. 1. Gross features. A solid white tumor measuring 12  13  13 mm is present
beneath the pleura.
Fig. 2. Microscopic features. a: Low power view. The tumor consists of lymphoid cells
with multifollicular appearances. HE, 40. b: Middle power view. The follicles were
composed of germinal center-like pale zones and surrounding marginal zone like dark
zone. HE, 100. c: High power view. The tumor cells consisted of many centrocytes and
a few centroblasts. HE, 200.
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(Fig. 3c), CD10 þ (Fig. 3d), CD23 þþ (Fig. 3e), cyclin D1 , CD21 þ,
CD79a þ, bcl-6 , CD3 , CD45RO , CD30 , CD15 , k-chain þþ
Fig. 3f, and l-chain . The Ki-67 labeling was 36%.
The overall appearances suggested that the lesion was primary
pulmonary follicular lymphoma, grade I. The surgical margins of
the resected lungwere free of tumor cells. The patient is now free of
disease three months after the operation, and is carefully follow-up
with a low dose of chemotherapy.
3. Discussion
Primary pulmonary follicular lymphoma is extremely rare.
Graham et al.1 reported that of the 18 primary pulmonary
lymphomas 16 were extranodal marginal zone B-cell lymphomas,
1 was Hodgkin’s disease, and 1 was follicular lymphoma. Ferraro
et al.3 who examined 48 patients with primary pulmonary
lymphomas showed that the lymphoma type was extranodular
marginal zone B-cell lymphoma of MALT type in 35 cases and other
types in 13 cases. Other studies did not found follicular lymphoma
in pulmonary lymphomas.2,4 Pulmonary follicular lymphoma is
very difﬁcult to differentiate from extranodal marginal zone B-cell
lymphoma of MALT type.5
In the present study, the tumor consisted of follicular structures.
The follicles lacked tingible body macrophages and the normal
follicular polarity. The presence of bcl-2 strongly suggests that the
present tumor is follicular lymphoma. In the present study, the
immunophenotypes of the follicles were as follows: CD45 þþþ,
CD20þþþ, bcl-2þþþ, CD5þ, CD10þ, CD23þþ, cyclin D1, CD21
þ, CD79a þ, bcl-6 , CD3 , CD45RO , CD30 , CD15 , k-chain
þþ, and l-chain . In general, immunophenotype of follicular
lymphoma is as follows: bcl-2þ, CD10þ, CD20þ, CD19þ, CD 22þ,
CD79a þ, bcl-6 þ, CD21 þ, CD23 þ, cyclin D1 .9 Despite of some
exceptions, the present case appears to mostly resemble follicular
lymphoma.
First, the present case should be differentiated from pulmonary
reactive lymphoid proliferation such as nodular lymphoid hyper-
plasia.10,11 This disease is frequently associated with Sjogren
syndrome. The present case consisted of only B-cells, and T-cells as
detected by CD3 and CD45RO were almost none, suggesting
a monoclonality of the proliferating lymphocytes. In addition, the
presence of light chain restriction (k-chain þþ, and l-chain ) in
the present case strongly suggests the monoclonality of the lesion.
Furthermore, positive bcl-2 protein in the present study excludesreactive hyperplasia, because bcl-2 protein is not expressed in the
reactive lymphoid hyperplasia.9 Histologically, the absence of tin-
gible body macrophages and the absence of follicular polarity favor
the neoplasmic natures of the present tumor. The Ki-67 labeling
was 36% in the present case, suggesting a neoplasmic nature of the
present tumor.
Second, the present case is difﬁcult to differentiate from extra-
nodal marginal zone B-cell lymphoma, the most common
Fig. 3. Immunohistochemical ﬁndings. a: The many follicles are positive for CD20.40. b: Each follicle is positive for bcl-2. 100. c: CD 5-positive cells are scattered in each follicle.
100. d: CD10-positive cells are scattered in each follicle. 100. e: There are many CD23-positive cells in each follicle. 100. f: The follicle cells are positive predominantly for k-
chain. 100.
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by proliferation of centrocyte-like cells, plasma cell, monocytoid
B-cells, lymphoepithelial lesions, and formation of germinal
centers.12 In the present case, such typical histological features of
this neoplasmwere absent. In addition, the positivity of bcl-2 in the
follicles in the present case strongly suggests that the tumor is not
extranodal marginal zone B-cell lymphoma. In general, this
neoplasm shows the following immunophenotypes: CD20 þ,
CD79a þ, CD5 , CD10 , CD23 , CD43 þ/, CD11C þ/, CD35 þ,
CD21þ, cyclin D1.12 This proﬁle is different from the present case.
Therefore, the author thinks that the present tumor is not extra-
nodal marginal zone B-cell lymphoma of MALT type.
Third, differentiation from a low grade B-cell lymphoma, mantle
cell lymphoma, is important. This neoplasm shows neoplasmic
proliferation of mantle zone lymphoma. Mantle cell lymphoma
may show nodular patterns, but the histological appearances of the
present tumor are different from mantle cell lymphoma. Mantle
cell lymphoma characteristically expressed cyclin D1,13 but the
present tumor lacked this molecule. The immunophenotypes of
mantle cell lymphoma are as follows: CD5þ, CD10, bcl-6, CD23
, CD43 þ, CD21 þ, CD35 þ, and cyclin D1 þ. The immunohisto-
chemical features of the present case are different from those of
mantle cell lymphoma. Therefore, the present case is not mantle
cell lymphoma.
Finally, the present study did not investigate molecular genetic
study. More molecular studies including Immunoglobulin rear-
rangement and bcl-2 rearrangement are necessary in the future
study.
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